文献速递慢性肾脏病

磷添加剂与早期慢性肾脏病阶段的白蛋白尿:一项随机对照试验

Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial.
PubMed 文献 · Am J Kidney Dis · 2016-11-16

本研究为随机双盲交叉试验,纳入31例早期慢性肾脏病成人患者,比较3周较高与较低磷摄入(通过添加市售饮料和早餐棒实现)对24小时尿白蛋白排泄和血浆成纤维细胞生长因子23的影响。结果显示较高磷添加剂摄入使24小时尿磷排泄增加505 mg/d,但未显著增加白蛋白尿或成纤维细胞生长因子23水平。

要点

  • 较高磷添加剂摄入3周使24小时尿磷排泄增加505 mg/d(95%CI 381至629,P<0.001)。
  • 较高磷摄入未显著增加白蛋白尿:较高 vs 较低为14.3%(95%CI -2.5%至34.0%,P=0.1)。
  • 血浆成纤维细胞生长因子23变化无显著差异:较高 vs 较低为3.4%(95%CI -5.9%至13.6%,P=0.4)。

核心结论

  • 3周较高磷食品添加剂摄入未显著增加白蛋白尿。
  • 需进一步研究确认这些结果。

研究设计与样本

  • 随机双盲交叉试验。
  • 纳入31例推测为早期慢性肾脏病成人(估算肾小球滤过率≥45mL/min/1.73m2;尿白蛋白-肌酐比值性别特异性切点:男性≥17mg/g,女性≥25mg/g)。
  • 干预为较高与较低磷摄入各3周,较高磷摄入通过添加市售饮食饮料和早餐棒实现。

主要发现

  • 基线磷摄入、24小时尿磷排泄和估算肾小球滤过率均值分别为1,113±549(SD)mg/d、688±300mg/d和74.6±22.0mL/min/1.73m2。
  • 基线尿白蛋白排泄中位数为82.7(IQR 39.6-174.1)mg/d。
  • 较高相比更低磷添加剂期间,研究产品磷摄入增加993mg/d(P<0.001),但背景磷摄入减少151mg/d(P=0.004)。
  • 较高磷添加剂消耗使24小时尿磷排泄增加505(95%CI 381至629)mg/d(P<0.001)。
  • 较高 vs 较低磷摄入白蛋白尿变化为14.3%(95%CI -2.5%至34.0%,P=0.1),成纤维细胞生长因子23变化为3.4%(95%CI -5.9%至13.6%,P=0.4)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 样本量小。
  • 干预持续时间短。
  • 干预期间背景饮食发生变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little is known about the effects of phosphorus additives on patients with kidney disease. STUDY DESIGN: Randomized, double-blind, crossover trial. SETTING & PARTICIPANTS: 31 adults with early stages of presumed chronic kidney disease (estimated glomerular filtration rate ≥ 45mL/min/1.73m2; urine albumin-creatinine ratio sex-specific cutoff points: men ≥ 17mg/g, women ≥ 25mg/g). INTERVENTION: Higher versus lower phosphorus intake for 3 weeks. Higher phosphorus intake was achieved by the addition of commercially available diet beverages and breakfast bars to diet. OUTCOMES: Change in 24-hour urine albumin excretion and plasma fibroblast growth factor 23 level. MEASUREMENTS: Two 24-hour urine collections and a single fasting blood draw at the end of each period. RESULTS: Mean baseline values for phosphorus intake, 24-hour urine phosphorus excretion, and estimated glomerular filtration rate were 1,113±549 (SD) mg/d, 688±300mg/d, and 74.6±22.0mL/min/1.73m2. Median urine albumin excretion of 82.7 (IQR, 39.6-174.1) mg/d. Although phosphorus intake from study products increased by 993mg/d (P<0.001) during the higher compared to lower phosphorus additive period, background phosphorus intake decreased by 151mg/d (P=0.004). Higher phosphorus additive consumption increased 24-hour urine phosphorus excretion by 505 (95% CI, 381 to 629) mg/d (P<0.001), but did not significantly increase albuminuria (higher vs lower: 14.3%; 95% CI, -2.5% to 34.0%; P=0.1) or fibroblast growth factor 23 level (higher vs lower: 3.4%; 95% CI, -5.9% to 13.6%; P=0.4). LIMITATIONS: Small sample size, short duration of intervention, changes in background diet during the intervention. CONCLUSIONS: A 3-week consumption of higher phosphorus food additives did not significantly increase albuminuria. Further studies are needed to confirm these results.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Chang AR, Miller ER, Anderson CA, et al. Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial. Am J Kidney Dis. 2016. PMID: 27865566. doi:10.1053/j.ajkd.2016.08.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。